Blog - QualityStocks

TuesdaySep 08, 2026 2:49 pm

QualityStocksNewsBreaks – Mobix Labs, Inc. (NASDAQ: MOBX) Secures Initial F-16 Component Production Order

Mobix Labs (NASDAQ: MOBX), a U.S.-based provider of advanced electronic components and connectivity solutions for aerospace, defense and mission-critical applications, announced its initial production order for components supporting the F-16 Fighting Falcon. The order, placed by a veteran-owned U.S. aerospace sustainment contractor supporting the U.S. Air Force F-16 fleet, includes EMI-filtered connectors manufactured at Mobix Labs military-approved facility in Irvine, California. Initial shipments have already been delivered, with the balance scheduled for delivery in the coming weeks. The F-16 order expands Mobix Labs presence across major U.S. fighter aircraft programs following previously announced growth supporting the F-22 Raptor, where component orders increased approximately fivefold over prior activity. Mobix Labs components also support the F-35 Lightning II and…

TuesdaySep 08, 2026 11:59 am

QualityStocksNewsBreaks – American Fusion Inc. (OTC: AMFN) Expands U.S. Patent Portfolio to 130 Applications, Advances National Exchange Uplisting Plans

American Fusion (OTC: AMFN), developer of the proprietary Texatron(TM) Fusion Engine(TM), reported the filing of 30 additional U.S. patent applications, expanding its intellectual property portfolio to 130 pending U.S. applications. The latest filings cover additional configurations and components of the Texatron(TM) platform, including aluminum fusion-confinement structures, toroidal and rifled chamber geometries, conductive components, helium-3 and deuterium fuel-injection configurations and electronic control systems. American Fusion has set an objective of filing more than 260 U.S. patent applications by the end of 2026, putting the company at approximately half of that target. The company also reported that it is evaluating a potential uplisting from the OTCQB Venture Market to a national securities exchange, with…

TuesdaySep 08, 2026 11:49 am

QualityStocksNewsBreaks – Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Strengthens Management Team as Santa Fe Mine Advances Toward 2027 Production Restart

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising. Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) announced three additions to its management team as the company continues its transition from mine developer to mine builder and targets a 2027 production restart at the Santa Fe Mine. Tony Gesualdo has rejoined Lahontan as vice president of exploration after previously serving as exploration manager from 2020 to 2023 and contributing to the Santa Fe Mine initial Mineral Resource Estimate. Michael Kubel joins as senior mine engineer, bringing more than a decade of Nevada open-pit gold mining and heap-leach experience, including work at the…

TuesdaySep 08, 2026 11:15 am

Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) (FSE: W1H) Builds Manufacturing, IND and Capital Foundation Ahead of Planned Clinical Translation

Disseminated on behalf of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) (FSE: W1H) and may include paid advertising. Investors in biotechnology often look for companies with a clear path toward clinical development, where regulatory preparation, manufacturing readiness and access to capital can help reduce execution risk. Onco-Innovations Ltd. is advancing ONC010, a nanoparticle-encapsulated PNKP inhibitor designed to target DNA repair pathways involved in cancer survival and treatment resistance. The company has strengthened its clinical foundation through manufacturing milestones, IND-enabling activities, strategic partnerships and a recent funding arrangement designed to support continued advancement of its oncology pipeline. For biotechnology investors, a…

TuesdaySep 08, 2026 11:10 am

QualityStocksNewsBreaks – Roth Capital Partners Hosts and Sponsors Investor Events Through June 2027

Roth Capital Partners is scheduled to host and sponsor more than a dozen investor events from September 2026 through June 2027, including seven ROTH-hosted conferences focused on healthcare, nuclear technology, solar and storage, technology and other growth sectors. Upcoming hosted events include the 5th Annual ROTH Healthcare Opportunities Conference on Sept. 29 in New York, the inaugural ROTH Critical Mass in Emerging Nuclear Technology on Oct. 1 in New York, the 13th Annual ROTH Solar & Storage Symposium at RE+ from Nov. 16-18 in Las Vegas and the 15th Annual ROTH Technology Conference from Nov. 17-18 in New York. The…

TuesdaySep 08, 2026 10:30 am

Frontieras North America Inc. Offers a Domestic Answer to America’s Imported Energy Vulnerability

The current geopolitical disruption has exposed what energy analysts have long documented: The United States, despite being one of the world's largest oil producers, still imports approximately 6.3 million barrels of crude oil per day. Frontieras is building a processing infrastructure to convert coal, a resource abundant in the United States, into the fuels and materials that American industry and transportation actually need. Frontieras is advancing its proprietary model from concept to construction. Recent world geopolitical events have made one argument impossible to dismiss: Energy systems built around imported feedstocks and foreign supply chains carry risks that domestic production does not.…

TuesdaySep 08, 2026 9:45 am

Say AU: LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) – True Junior Gold Producer with Near-Term Gold Production Strategy

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. Lafleur Minerals: Fully permitted Beacon Gold Mill and tailings pond, nearby Swanson Gold Deposit, make Lafleur a near-term gold producer in the Abitibi Gold Belt, ValDor, Canada. The Val-d’Or mining camp sits in the heart of the prolific Abitibi Greenstone Belt, one of the richest gold-producing regions in the world. Abitibi Gold Belt junior miner LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) is about to move from Beacon Gold Mill recommissioning stage to gold production at its fully permitted and refurbished Beacon Gold Mill, drawing on mineralized material that…

TuesdaySep 08, 2026 9:30 am

QualityStocksNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML) Sets Q4 Biotech Spin-Off as Company Sharpens Critical Minerals Focus

Greenland Mines (NASDAQ: GRML) announced a series of corporate milestones as it transitions into a focused rare earths and critical minerals company, including plans to spin off its biotechnology division in the fourth quarter of 2026. Nasdaq has formally approved the company application relating to its March 2026 transaction, resolving prior deficiencies and bringing Greenland Mines into full compliance with listing requirements. The company also completed its acquisition of the Sarfartoq project on Sept. 1 following approval by the Government of Greenland. An independent S-K 1300 Initial Assessment for the ST1 deposit estimated a high-case pre-tax net present value of…

TuesdaySep 08, 2026 9:10 am

QualityStocksNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Retains P&E Mining Consultants to Support Murdock Mountain Project

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF), a B.C.-based organic sedimentary phosphate exploration company, retained P&E Mining Consultants Inc. to provide independent technical support for its wholly owned Murdock Mountain Property in Elko County, Nevada. P&E will support ongoing technical evaluation, geological modeling and staged de-risking of the sedimentary phosphate horizon, drawing on experience in geological interpretation, 3D modeling, Mineral Resource and Mineral Reserve Estimates, Preliminary Economic Assessments, Feasibility Studies and mine planning. P&E also has direct phosphate-sector experience involving projects for First…

TuesdaySep 08, 2026 9:10 am

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Gains Editorial Spotlight Following FDA Clearance for Lucid-MS Phase 2 Trial

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) was featured in BioMedWire editorial coverage highlighting FDA clearance of the company Investigational New Drug (“IND”) application to begin a randomized, double-blind, placebo-controlled phase 2 trial of Lucid-MS in people with multiple sclerosis (“MS”). Lucid-MS, also known as Lucid-21-302, is a patented, first-in-class drug candidate designed to inhibit peptidyl arginine deiminase 2 (“PAD2”) and target demyelination rather than broadly suppressing the immune system. The editorial notes that Lucid-MS previously completed phase 1 testing in healthy volunteers, with the company…

Site Search

Company Search